$33.19
0.431.31%
At close: Jul 17, 5:00 PM EST
$33.19
N/A
After Hours: Jul 17, 4:00 PM EST
ArriVent BioPharma Inc Earnings Estimates
AVBPNASDAQ
ArriVent BioPharma Earnings Estimates, EPS & Revenue | NASDAQ:AVBP
ArriVent BioPharma (AVBP) is scheduled to report Q2 earnings on August 10, 2026. Analysts estimate EPS of $-0.98 and quarterly revenue of N/A.
In the most recent quarter (Q1), ArriVent BioPharma reported EPS of $-0.96, missing estimates of $-0.89 by 0.08%. Revenue came in at $0, meeting the estimate of $0 by 0.00%.
Over the last 4 quarters, ArriVent BioPharma has averaged an EPS surprise of 0.13% and a revenue surprise of 0.00%.
Earnings Date
Aug 10
EPS Estimate
$-0.980
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
ArriVent BioPharma Earnings History
Analyze the earnings history of ArriVent BioPharma using advanced sorting and filters.
Loading calendar...
ArriVent BioPharma (AVBP) Earnings Per Share
The chart below shows ArriVent BioPharma's reported EPS compared to analyst estimates over recent quarters.
ArriVent BioPharma (AVBP) Revenue
The chart below shows ArriVent BioPharma's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is ArriVent BioPharma (NASDAQ:AVBP) reporting earnings?
ArriVent BioPharma (AVBP) is scheduled to report earnings on August 10, 2026. The last reported earnings were for reported on May 11, 2026 for Q1.
What were the latest earnings per share (EPS) for ArriVent BioPharma (NASDAQ:AVBP)?
The Actual EPS was $-0.96, which missed the estimate of $-0.89.
What were ArriVent BioPharma’s (NASDAQ:AVBP) revenues?
The Actual Revenue was $0, which hit the estimate of $0.
